Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

4 Uranium Stocks You Should Buy Now

Page 1 of 2

What are the best uranium stocks? The basic materials sector has been struggling lately, having only posted average gains of 1.9% in the past 12 months. That doesn’t mean that the sector is going to stay this way, and in fact provides an opportunity to follow the oldest mantra in investing: “buy low and sell high”. Today we will be focusing on a precious metal, which has seen its price rise by more than 6.2% over the last month, uranium. The metal’s main industrial use is as fuel in nuclear power plants, providing about 14% of the world’s electricity. Hence, Japan’s recent announcement that it will be restarting its nuclear power plants more than four years after the Fukushima nuclear disaster, and the commitment of the U.S to reduce emissions, which also puts nuclear power in a favorable light, had a positive impact on the metal’s price. Scanning our database, we have come up with the four most popular companies among hedge funds that are focused on the extraction of this metal. Read on to find out who they are.


Most investors don’t understand hedge funds and indicators that are based on hedge funds’ activities. They ignore hedge funds because of their recent poor performance in the bull market. Our research indicates that hedge funds underperformed because they aren’t 100% long. Hedge fund fees are also very large compared to the returns generated and they reduce the net returns experienced by investors. We uncovered that hedge funds’ long positions actually outperformed the market. For instance the 15 most popular small-cap stocks among funds beat the S&P 500 Index by more than 60 percentage points since the end of August 2012. These stocks returned a cumulative of 118% vs. a 57.6% gain for the S&P 500 Index (read the details). That’s why we believe investors should pay attention to what hedge funds are buying (rather than what their net returns are).

4. Rio Tinto plc (ADR) (NYSE:RIO)

Investors with Long Positions (as of June 30): 18

Aggregate Value of Investors’ Holdings (as of June 30): $241.11 Million

At the end of March, 16 hedge funds had investments worth $321.76 million in Rio Tinto plc (ADR) (NYSE:RIO). The stock price depreciated by a little over 4% during the June quarter, while it is down by about 20% so far this year. Although Rio Tinto plc (ADR) (NYSE:RIO) is slightly less popular than BHP Billiton Limited (ADR) (NYSE:BHP) as far as hedge fund sentiment is concerned, many analysts actually favor the former, given its discipline, restructuring potential, cheap valuation, and dividend yield, which currently stands at 5.64%. Such analyst firms include UBS and T. Rowe Price. Rio Tinto’s largest shareholder within our database, David Shaw‘s D E Shaw, increased its holding in the company by 14% to about 764,100 shares valued at $13.49 million during the second quarter.

3. AngloGold Ashanti Limited (ADR) (NYSE:AU)

Investors with Long Positions (as of June 30): 18

Aggregate Value of Investors’ Holdings (as of June 30): $585.10 Million

During the second quarter, the hedge fund interest in AngloGold Ashanti Limited (ADR) (NYSE:AU) fell from 21 firms with a total investment of $635.16 million in the company. John Paulson‘s Paulson & Co reduced its stake in the company by 1% to 26.03 million shares during this period. As the name suggests, AngloGold Ashanti Limited (ADR) (NYSE:AU)’s main exposure is to gold, but the company also produces uranium, silver, and sulfuric acid.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!